Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.


Recall -- Firm Press Release

FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company.

Deseo Rebajar Inc. Issues Voluntary Puerto Rico Recall of Adipotrim XT Due to Underclared Fluoxetine


— November 14, 2013 – (Worldwide) Deseo Rebajar Inc., is voluntarily recalling lot #052012 of Adipotrim XT to the consumer level. The FDA laboratory analysis of this dietary supplement found to contain undeclared Fluoxetine. Flouxetine is an FDA approved drug in a class of drugs called selective serotonin reuptake inhibitors (SSRIs)  used for treating depression, bulimia, obsessive-compulsive disorder (OCD), panic disorder, and premenstrual dysphonic disorder (PMDD), making Adipotrim XT an unapproved drug.

Uses of SSRIs have been associated with serious side effects including suicidal thinking, abnormal bleeding, and seizures. In patients on other medications for common conditions (aspirin, ibuprofen, or other drugs for depression, anxiety, bipolar illness, blood clots, chemotherapy, heart conditions, and psychosis), ventricular arrhythmia or sudden death can occur. No illnesses or injuries have been reported to Deseo Rebajar Inc. to date in connection with the use of this product.

Adipotrim XT is marketed as a natural herb dietary supplement for weight loss.  The recalled products are packaged in 30-count plastic bottles labeled with lot number #052012

The product lot was sold directly to individual customers in our offices in Fajardo, Caguas and Bayamon and in website We sincerely regret any inconvenience to our customers.

Deseo Rebajar Inc. is notifying their distributors and customers by phone. Consumers/Distributors/Retailers that have the product being recalled should stop using and return the product immediately to the place of purchase.

Consumers with questions should contact Deseo Rebajar Inc. at 787.961.6464 or via e-mail at Monday - Friday, 8:00 am - 5:00 pm, [GMT time zone]. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse events that may be related to the use of this product may be reported to FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Online:
  • Regular Mail: use postage-paid, pre-addressed Form FDA 3500 available at: Mail to address on the pre-addressed form.
  • Fax: 1-800-FDA-0178
  • This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
  • Deseo Rebajar Inc. is taking this voluntary action because it is committed to the health and safety of its customers and to the quality of its select brands. We are working diligently to make available appropriate natural herbal regulations. We are moving forward with new custom formula. We value our relationship with you and will continue to provide you with the best possible service. Thank you for your continued business and allowing us to be a trusted partner.


RSS Feed for FDA Recalls Information [what's this?]

Recalled Product Photos Are Also Available on FDA's Flickr Photostream.

Page Last Updated: 11/21/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English